(ACER) $1.35..FDA Decision next month ..Market cap only $22 million ,,this low floater could run to $2.50-3 ahead of the FDA date
ACER-001 (sodium phenylbutyrate) The FDA has assigned a new PDUFA target action date of January 15, 2023, on the pending NDA, following the FDA’s acceptance for review of Acer’s resubmitted NDA for ACER-001 for the treatment of patients with UCDs
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.